Cardiol Therapeutics Inc (CRDL)
1.76
-0.08
(-4.35%)
USD |
NASDAQ |
Apr 24, 16:00
1.76
0.00 (0.00%)
Pre-Market: 20:00
Cardiol Therapeutics Cash from Operations (TTM): -18.65M for Dec. 31, 2023
Cash from Operations (TTM) Chart
Historical Cash from Operations (TTM) Data
| Date | Value |
|---|---|
| December 31, 2023 | -18.65M |
| September 30, 2023 | -23.63M |
| June 30, 2023 | -22.14M |
| March 31, 2023 | -20.06M |
| December 31, 2022 | -20.92M |
| September 30, 2022 | -14.50M |
| June 30, 2022 | -18.22M |
| March 31, 2022 | -21.40M |
| December 31, 2021 | -18.78M |
| September 30, 2021 | -17.38M |
| June 30, 2021 | -14.92M |
| Date | Value |
|---|---|
| March 31, 2021 | -10.59M |
| December 31, 2020 | -6.814M |
| September 30, 2020 | -7.224M |
| June 30, 2020 | -6.538M |
| March 31, 2020 | -7.337M |
| December 31, 2019 | -8.574M |
| September 30, 2019 | -12.83M |
| June 30, 2019 | -12.37M |
| March 31, 2019 | -11.19M |
| December 31, 2018 | -8.406M |
Cash From Operations Definition
Cash flow from operations is a major line item of the statement of cash flows. This metric tracks the movement of cash flows for the overall operating activities of the company. A few examples of operating activities include change in receivables, change in inventories, and changes in current assets.
Cash from Operations (TTM) Range, Past 5 Years
-23.63M
Minimum
Sep 2023
-6.538M
Maximum
Jun 2020
-14.89M
Average
-14.92M
Median
Jun 2021
Cash from Operations (TTM) Benchmarks
| Aurinia Pharmaceuticals Inc | -33.46M |
| Acasti Pharma Inc | -13.57M |
| Edesa Biotech Inc | -6.252M |
| Lexaria Bioscience Corp | -5.209M |
| Xenon Pharmaceuticals Inc | -145.33M |